Nasal CPAP increases alveolar number in a rhesus monkey model of moderate prematurity

Cindy T McEvoy1, Kelvin D MacDonald1, Lyndsey E Shorey-Kendrick2

  • 1Department of Pediatrics, Oregon Health and Science University, Portland, OR, USA.

PubMed

Insights

Nasal continuous positive airway pressure (nCPAP) in moderate to late preterm (MLP) infants promotes alveolar development. This study in a rhesus monkey model showed nCPAP increased alveoli numbers, suggesting potential benefits for infant respiratory health.

Area of Science:

  • Neonatal physiology
  • Respiratory medicine
  • Developmental biology

Background:

  • Moderate to late preterm (MLP) infants often experience respiratory issues.
  • Mechanical lung distention may enhance lung growth and alveolar development.
  • The effect of nCPAP on MLP infant lung development requires investigation.

Purpose of the Study:

  • To investigate the impact of nasal continuous positive airway pressure (nCPAP) on lung development in moderate to late preterm (MLP) infants.
  • To establish a rhesus monkey model for studying nCPAP effects on prematurity-related lung changes.

Main Methods:

  • Rhesus monkey fetuses were delivered at 85% gestation (equivalent to 32-34 weeks).
  • Infants received either nCPAP or sham nCPAP for 9 days, 12 hours daily.
  • Pulmonary function tests and necropsy for lung structural and gene expression analysis were performed.

Main Results:

  • nCPAP treatment led to a significant increase in alveoli numbers compared to the sham group.
  • Functional and anatomical changes indicated enhanced alveolarisation in the nCPAP group.
  • Gene expression profiles were similar between nCPAP and sham groups, but distinct from controls.

Conclusions:

  • nCPAP administration in MLP infants stimulates alveolarisation.
  • This intervention shows minimal other structural or functional changes.
  • Further research is needed to determine the long-term respiratory health benefits for infants.
Abstract